Feiba



Feiba

Product Specs Feiba
Manufacturer Name Takeda
Indications For use in hemophilia A and B patients with inhibitors for:

  • Control and prevention of bleeding episodes
  • Perioperative management
  • Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.
    		•
    Contraindications Patients who havea history of anaphylactic or severe hypersensitivity reactions to FEIBA or any of its components, including factors of the kinin generating system, disseminated intravascular coagulation (DIC) or acute thrombosis or embolism (including myocardial infarction).
    Viral Safety Process Vapor heat treatment and 35 nm nanofiltration
    Product Half-Life N/A; Dosing intervals: 6-12 hours by type of hemorrhage
    Manufacturing Method Plasma Derived
    Storage Requirements
  • Store at 36°F to 77°F (2°C to 25°C)
  • Store in the original package in order to protect from light.
  • Do not freeze.
    		•
    Shelf Life 24 months from manufactured date
    Nominal Vial Size & Diluent Volume 500 or 1000 IU/20 mL
    2500 IU/50 mL


    Return to Manufacturer Name listing Return to Factor Type listing